TARDBP and amyotrophic lateral sclerosis: Osaki et al. developed an ALS-on-a-chip technology (i.e., an ALS motor unit) by co-culturing TDP-43 pathogenic variants with sporadic ALS patient-iPSC-derived MN spheroids and normal human-derived 3D SkM bundles [67].